Across many IDNs, 340B is no longer being discussed solely in terms of compliance or financial contribution, but increasingly as a strategic decision point in broader pharmacy and enterprise planning. This session brings pharmacy executives together to discuss how leadership teams are approaching the future of their 340B programs, whether through expansion, restructuring, diversification of reliance, or reevaluation of program role within overall pharmacy strategy. The conversation will focus on how executives are thinking beyond day-to-day management and into longer-term positioning, trade-offs, and organizational intent.

Join pharmacy peers in a discussion focused on strategic decision-making frameworks and how systems are rethinking the future role of 340B within pharmacy enterprise strategy.

Learning Objectives:
1. Examine how IDNs are reassessing the strategic role of 340B within pharmacy operations. 
2. Identify different approaches to long-term program positioning, dependence, or diversification. 
3. Discuss how executive teams are incorporating 340B into broader enterprise planning decisions. 
4. Compare peer perspectives on future-oriented 340B strategy and structural choices.